Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has clinched a new contract. Recently, the company announced that its Sunrise and CareInMotion platforms have been selected by Texas-based Wise Health System that provides inpatient and outpatient services at 79 service locations in eight counties. These include hospitals, primary care and specialty clinics, physical therapy and rehabilitation centers, imaging centers, and bariatric surgery program offices.
Allscripts Healthcare is progressing well with its Sunrise and CareInMotion platforms. During the last-reported second quarter of 2016, the company expanded its client base. As a result, it recorded strong double-digit growth in bookings, primarily attributable to new clients.
Sunrise is a highly configurable electronic health record that offers workflows to drive adoption of clinical decision support. CareInMotion is a comprehensive, adaptable framework that enables healthcare organizations to address their specific population health priorities, such as connectivity, care coordination, analytics and patient engagement.
Allscripts Healthcare is a leading provider of healthcare information technology solutions.
Going forward, we believe that the new contract will help Allscripts Healthcare’s platforms gain better market traction, which will lead to increased business.
It has been a story of constant achievements for Allscripts Healthcare’s platforms. From winning industry recognition to fetching new clients, the platforms have indeed lived up to expectations and have helped the company grow over time.
Zacks Rank and Key Picks
Currently, Allscripts Healthcare carries a Zacks Rank #3 (Hold).
Better-ranked stocks in the medical sector include GW Pharmaceuticals plc (NASDAQ:GWPH) , NuVasive, Inc. (NASDAQ:NUVA) and Quidel Corp. (NASDAQ:QDEL) . Each of these stocks sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
ALLSCRIPTS HLTH (MDRX): Free Stock Analysis Report
NUVASIVE INC (NUVA): Free Stock Analysis Report
GW PHARMA-ADR (GWPH): Free Stock Analysis Report
QUIDEL CORP (QDEL): Free Stock Analysis Report
Original post
Zacks Investment Research